Life Sciences BPO Market (By Services: Pharmaceutical Outsourcing, Medical devices outsourcing, Contract sales and marketing outsourcing, Others; By Application: Pharmaceuticals, Medical Device applications, Biopharmaceuticals, Research and development, others; By Protocol: Development, Site Management) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2030


The global life sciences BPO market size was estimated at USD 376.3 billion in 2021 and it is expected to reach around USD 835.2 billion by 2030, poised to grow at a compound annual growth rate (CAGR) of 9.26% during the forecast period 2022 to 2030.

  • By service, the pharmaceutical outsourcing segment accounted highest revenue share of around 55% in 2021.
  • Asia Pacific region has had highest revenue share of over 38.6% in 2021.

Life Sciences BPO Market Size 2022 To 2030

Life sciences organizations and companies have increased the massive developments and productions with the good productivity in the health sectors which help to boost the market growth during the forecast period. The life sciences BPO involves study and research of  development  and manufacturing of the pharmaceuticals, medical devices,  bio-medical technologies, biotechnology based food and medicines, nutraceuticals, cosmecuticals, food processing and other products to increase the productions and manufacturing with the improved clinical trials and safety of the products. Impact of Covid-19 the pandemic situation is affected to a greater extent with the increased market growth of life sciences BPO, increased demands from the health sector in pandemic situation for covid-19 testing kits and for the development and trials of the vaccines.   

Growth factors

The significant growth of the life sciences BPO market to increase day by day due to increased chronic disorders such as cancer, tuberculosis, infectious disease and many more affected the market to grow. Decreased Covid-19 cases with increased vaccination drives the market to a greater extent. Increased adapting of the new innovative technologies and development of the drug and safety of the drug with performed clinical trials and increased production and development with good productivity.

Increased research and development process for developing and manufacturing new drug having higher efficacy and safety. In life sciences companies take advantages of data management with decreased costing of the products with improved solutions and services with the machine learning and performing the task over a software using cloud technology.

Pharmacovigilance is the major role for showing the life science future with the massive growth of the market. Increased activities in the pharmaceutical companies with higher efficiency and efficacy to develop the drug with improved clinical trials, research and development activities and safety of the drug to avoid the adverse reactions of the drug. The key market players involved in introducing, manufacturing, producing and developing new methods and technologies have helped to boost the market to grow.   

Report Scope of the Life Sciences BPO Market

Report Coverage Details
Market Size in 2022

USD 411.16 Billion

Market Size by 2030

USD 835.2 Billion

Growth Rate from 2022 to 2030 CAGR of 9.26%
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered Services, Application, Protocol and Geography
Companies Mentioned

International Business Machines Corp, IOVIA, PAREXEL International Corp, Lonza Group, Infosys.Ltd, ICON plc, Genpact LTD, Covance, Inc. (Labcorp), Catalent, Inc, Boehringer Ingelheim Gmbh, Atos SE, Accenture plc, Syneos Health, Inc, Charkes River Laboratories International, Inc, Wuxi AppTec Co, Ltd, Medpace Holdings, Inc, PRA Health Sciences, Inc, Cognizant Technology Solutions, Quintiles Transactional Corporation, and Others

 

Market Drivers

The increasing life sciences BPO market with increased research and development process with increased strategies of outsourcing plays a major role in pharmaceutical companies. Strategic out sourcing has become the important factor in the development in industries with multiple facilities from screening of the drugs to determining the lead toxicology, preclinical studies, clinical studies, clinical trials, manufacturing and marketing.

In developing new pharmaceutical outsourcing market. CMOs and CROs are involved in last few years which have contributed for the growth of the life sciences market. Outsourcing has become the important strategy door pharmaceutical development, biotechnology development in life sciences industries, and transfer of non-core activities to outsourcing. Increased focused on distribution networking, market strategies, research and development have raised the market growth.

Increased productivity and with the increased safety have thrived the market to grow. The market players involved in the life sciences for introducing new developments have contributed to boost the market growth to a larger extent.

Market Challenges 

The major factor that challenges the growth of life sciences market as per investigation of the life sciences market lack of awareness among the people and lack of skill  work is required along with the developments and new features updates, new procedures and clinical work  to be performed required professional skill work. Lack of skill may hamper the growth of the life sciences BPO market during the forecast period.

Audience being targeted belong to regions which are the involved in the global market which differ in income sources and capacity of investing. Increased investing in the production and development of the new drug developments and increased research and clinical trials in different countries with same drug is also the challenging task for the market to grow.

Out sourcing of drugs to various countries which involves different guidelines a regulatory process for drug, filing, clinical trials. Involved market players in introducing new developments and technologies have increased the market revenue share during the forecast period. 

Market Opportunities

  • Under developed Countries with new technology- Developing countries with new newly developed innovative technology across various regions with new facilities and developments having higher efficacy, efficiency and good productivity of newly developed drugs with new trials, clinical trials and safety of the drug for increased therapeutic index.
  • Increased investment- Increased investments and funds for increasing drug discovery services, clinical trial studies, increased safety of the drug with pharmacovigilance study and many more. Increased medical outsourcing, sales and marketing services and others have increased the market rate.
  • Market Players- Increased wide research and wide development process in the life sciences carried out by the market players involves in developing new drug and manufacturing and producing new technologies with increased investment by the key market players have increased the market rate of life sciences to a larger extent. 

Services Insights

Pharmaceutical Outsourcing - Increasing life sciences BPO with various developments have raised the market multiples segments involved in the market for rising the growth of the market. Which involves contract manufacturing of the market such as for production active pharmaceutical ingredient is the major role for developing and discovering drug with various formulations available and for developing the dosage form with higher efficacy and no adverse reactions and finally producing the dosage form and packaging done. Contract research organization involves discovery of the drug and clinical trials are done such preclinical studies and clinical trials studies, clinical trial I, II, III, IV to study the efficacy and safety of the drug in limited population the study is performed, Regulatory services and pharmacovigilance have increased the market of life sciences.

Life Sciences BPO Market Share, By Services, 2021 (%)

Medical Deceives Outsourcing - Increased services in life sciences have raised the market to enhance the requirements and increased research. Medical devices outsourcing involves contract manufacturing market such as electronic manufacturing services required in patients’ health care safety with increased production of medical devices with developed technologies and research development process, finished goods process, raw materials components.

Application Insights

Segmentation of life sciences BPO on the basis of application wide utilization of life sciences in various sectors in pharmaceutical development of various drugs which is the most widely adapted in the current world due to increasing chronic disorders and utilization of medical devices in health care center and utilization in biopharmaceuticals. Hospitals and clinics are the major role players for development of the life science market with increased research and developments have enhanced the market of life sciences to a greater extent. 

Life Sciences BPO Market Share, By Region, 2021 (%)

Regions Revenue Share in 2021 (%)
North America 27.50%
Asia Pacific 38.60%
Europe 22%
Latin America 8%
MEA 3.90%

 

Geography Insights

On the basis of geography, the region of North America has gained the top most position in the life sciences with increased development of drug, with increased government support with policies such as reimbursement, increased manufacturing and costing of the drugs and medical devices and treatments. Which expands the market to greater extent.

Second highest region to hold the market of life sciences BPO is Europe region countries involved are Sweden, the UK, and Germany with developed technologies and developments in advanced health care centers have driven the market to grow high.

Third highest region is Asia Pacific region with increased revenue share globally and rise of the market countries involved are India, China, Japan, increased government attention towards the development of life science process, other regions such as Latin America and Middle East and Africa have low market share with low infrastructure affect the market growth and decreased market rate of life sciences. 

Recent developments

  • In the year 2017 September, Laboratory Corporation of America acquired children which is the part of company’s CDD segment. This acquisition strengthens its hold in the CRO services market.
  • In the year 2018 June, Laboratory corporation of North America acquired Sciformix Corporation an outsourcing company engaged with offering pharmacovigilance and regulatory solutions in biopharmaceutical and medical device companies. This adapted acquisition holds the company’s position high in development of drug and devices and marketing of pharmacovigilance and market access solutions.
  • In the year 2019 November, Syneos Health, Inc collaborated with Aicure and AI to gain the position in the market with developments like advance data analytics company for success trials.

Key market players

  • International Business Machines Corp
  • IOVIA
  • PAREXEL International Corp
  • Lonza Group
  • Infosys.Ltd
  • ICON plc
  • Genpact LTD
  • Covance, Inc. (Labcorp)
  • Catalent, Inc
  • Boehringer Ingelheim Gmbh
  • Atos SE
  • Accenture plc
  • Syneos Health, Inc
  • Charkes River Laboratories International, Inc
  • Wuxi AppTec Co, Ltd
  • Medpace Holdings, Inc
  • PRA Health Sciences, Inc
  • Cognizant Technology Solutions
  • Quintiles Transactional Corporation
  • ProMab Biotechnologies, Inc
  • Boehringer Ingelheim Gmbh 

Segments covered in the report

(Note*: We offer report based on sub segments as well. Kindly, let us know if you are interested)

By Services 

  • Pharmaceutical Outsourcing
    • Contract Manufacturing Market
      • API
      • Finished Dose Form
      • Packaging
    • Contract Research Organizations
      • Drug Discovery
      • Pre-clinical Studies
      • Clinical Trial Studies
      • Regulatory Services
      • Pharmacovigilance
  • Medical devices outsourcing
    • Contract Manufacturing Market
      • Electronic Manufacturing Services
      • Finished Goods
      • Raw Materials/ Components
    • Contract Research Organizations
      • Regulatory Consulting Services
      • Product Design and Development Services
      • Product Testing Services
      • Product Implementation Services
      • Product Upgrade Services
      • Product Maintenance Services
  • Contract sales and marketing outsourcing
  • Others

By Application

  • Pharmaceuticals
  • Medical Device applications
  • Biopharmaceuticals
  • Research and development
  • others

By Protocol

  • Development
  • Site Management

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions

What is the current size of life sciences BPO market?
The global life sciences BPO market size was accounted at USD 376.3 billion in 2021 and it is expected to reach around USD 835.2 billion by 2030.
The global life sciences BPO market is poised to grow at a CAGR of 9.26% from 2022 to 2030.
The major players operating in the life sciences BPO market are International Business Machines Corp, IOVIA, PAREXEL International Corp, Lonza Group, Infosys.Ltd, ICON plc, Genpact LTD, Covance, Inc. (Labcorp), Catalent, Inc, Boehringer Ingelheim Gmbh, Atos SE, Accenture plc, Syneos Health, Inc, Charkes River Laboratories International, Inc, Wuxi AppTec Co, Ltd, Medpace Holdings, Inc, PRA Health Sciences, Inc, Cognizant Technology Solutions, Quintiles Transactional Corporation, and Others
Increased developing new technologies and new drug developments with increased research and development drives the market to grow high.
Asia Pacific region will lead the global life sciences BPO market during the forecast period 2022 to 2030.
  • Report Code:2072
  • Category:Healthcare
  • No. of Pages:150+
  • Format:PDF/PPT/Excel
  • Status:Published

PROCEED TO BUY

   USD 4500
   USD 7000
   USD 9000

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample